MCID: OBS001
MIFTS: 48

Obstructive Jaundice malady

Categories: Gastrointestinal diseases

Aliases & Classifications for Obstructive Jaundice

Aliases & Descriptions for Obstructive Jaundice:

Name: Obstructive Jaundice 12 14
Jaundice, Obstructive 42 69
Obstructive Hyperbilirubinemia 12
Cholestatic Jaundice Syndrome 12
Obstructive Jaundice Nos 12
Cholestatic Jaundice 12
Jaundice Obstructive 52
Jaundice Cholestatic 52

Classifications:



External Ids:

Disease Ontology 12 DOID:13603
MeSH 42 D041781
NCIt 47 C34742
UMLS 69 C0022354

Summaries for Obstructive Jaundice

MalaCards based summary : Obstructive Jaundice, also known as jaundice, obstructive, is related to b-cell lymphomas and choroiditis, and has symptoms including icterus and jaundice (not of newborn). An important gene associated with Obstructive Jaundice is ALPP (Alkaline Phosphatase, Placental), and among its related pathways/superpathways are Folate Metabolism and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Lactulose and Ceftriaxone have been mentioned in the context of this disorder. Affiliated tissues include liver, pancreas and lung, and related phenotypes are growth/size/body region and homeostasis/metabolism

Related Diseases for Obstructive Jaundice

Diseases related to Obstructive Jaundice via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 355)
id Related Disease Score Top Affiliating Genes
1 b-cell lymphomas 29.7 F2 GGT1 GPT
2 choroiditis 29.4 ALB CXCL8 IL6 TNF
3 xanthogranulomatous cholecystitis 29.3 CD79A CXCL8 TNF
4 histiocytosis 29.3 CD79A CXCL8 IL6 TNF
5 acute monocytic leukemia 29.1 ALB F2 GPT HGF SLC17A5
6 mirizzi syndrome 11.1
7 cholestasis, benign recurrent intrahepatic 11.1
8 adrenocorticotropic hormone deficiency 10.9
9 cholestasis, benign recurrent intrahepatic, 2 10.9
10 bile acid synthesis defect, congenital, 1 10.9
11 pancreatitis 10.5
12 gastric neuroendocrine tumor type 1 10.3 GPT SLC17A5
13 phaeochromocytoma 10.3 ALB TTR
14 hepatitis 10.3
15 vps11-related autosomal recessive hypomyelinating leukodystrophy 10.3 IL6 TNF
16 congenital dyserythropoietic anemia 10.3 ALB TNF
17 nondystrophic myotonia 10.3 ALB F2
18 uterine inflammatory disease 10.3 EDN1 REN
19 ringed hair 10.3 GGT1 GPT
20 distal monosomy 14q 10.3 IL6 REN
21 ehlers-danlos syndrome, periodontal type 1 10.3 ALB TTR
22 radiation induced cancer 10.3 GPT SLC17A5
23 inner ear disease 10.3 ALB IL6 TTR
24 atopic dermatitis 6 10.3 ALB CD79A
25 migraine with aura 10.3 IL6 SLC17A5 TNF
26 vogt-koyanagi-harada disease 10.3 GPT IL6 TNF
27 leydig cell hypoplasia 10.3 IL6 SLC17A5 TNF
28 spinocerebellar ataxia 25 10.3 ALB IL6 REN
29 papilledema 10.3 IL6 TNF TTR
30 familial progressive hyperpigmentation 10.2 F2 GPT
31 plummer's disease 10.2 ALB IL6 TNF
32 rift valley fever 10.2 ALB IL6 TNF
33 colloid adenoma 10.2 ALB CD79A
34 mansonelliasis 10.2 ALB IL6 TNF
35 central nervous system leiomyoma 10.2 ALB IL6 TTR
36 acute necrotizing encephalitis 10.2 ALB GGT1 REN
37 ischemic optic neuropathy 10.2 ALB F2 IL6
38 alopecia 10.2 GGT1 GPT SLC17A5
39 lymphoma 10.2
40 high-grade dysplasia in patients with barrett esophagus 10.2 EDN1 REN SLC17A5
41 pulpitis 10.2 F2 SLC17A5 TNF
42 schneiderian carcinoma 10.2 ALB CD79A
43 autoimmune disease of central nervous system 10.2 F2 IL6 TNF
44 petrositis 10.2 ALB EDN1 REN
45 pyelitis 10.2 ALB F2 GPT
46 fallopian tube leiomyosarcoma 10.2 ALB F2 GPT
47 congenital nystagmus 10.2 ALB CD79A REN
48 hypothyroidism, congenital nongoitrous, 5 10.2 GGT1 REN
49 central nervous system lymphoma 10.2 EDN1 IL6 TNF
50 acute female pelvic peritonitis 10.2 CD79A TTR

Graphical network of the top 20 diseases related to Obstructive Jaundice:



Diseases related to Obstructive Jaundice

Symptoms & Phenotypes for Obstructive Jaundice

UMLS symptoms related to Obstructive Jaundice:


icterus, jaundice (not of newborn)

MGI Mouse Phenotypes related to Obstructive Jaundice:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.85 EDN1 F2 GGT1 HGF IL6 NTS
2 homeostasis/metabolism MP:0005376 9.73 NTS REN SLC17A5 SLC25A13 TNF TTR
3 renal/urinary system MP:0005367 9.17 ALB CD79A EDN1 GGT1 IL6 REN

Drugs & Therapeutics for Obstructive Jaundice

Drugs for Obstructive Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 57)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lactulose Approved Phase 4 4618-18-2 11333
2
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
3
Ofloxacin Approved Phase 4 82419-36-1 4583
4
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
5 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
6 Cytochrome P-450 Enzyme Inhibitors Phase 4
7 Topoisomerase Inhibitors Phase 4
8 Anti-Bacterial Agents Phase 4
9 Anti-Infective Agents Phase 4
10 Renal Agents Phase 4
11 Antibiotics, Antitubercular Phase 4
12 Antitubercular Agents Phase 4
13
Trioxsalen Approved Phase 2, Phase 3 3902-71-4 5585
14 Liver Extracts Phase 3,Phase 2,Phase 1
15 Hematoporphyrin Derivative Phase 2, Phase 3
16 Dihematoporphyrin Ether Phase 2, Phase 3
17
Ursodeoxycholic acid Approved, Investigational Phase 2 128-13-2 31401
18
Menthol Approved Phase 2 2216-51-5 16666
19
Pancrelipase Approved Phase 2 53608-75-6
20
Neostigmine Approved, Vet_approved Phase 1, Phase 2 59-99-4 4456
21 pancreatin Phase 2
22
Bilirubin Phase 2,Phase 1 635-65-4 5280352
23 Cholagogues and Choleretics Phase 2
24 Gastrointestinal Agents Phase 2
25 Cholinergic Agents Phase 1, Phase 2
26 Cholinesterase Inhibitors Phase 1, Phase 2
27 Neurotransmitter Agents Phase 1, Phase 2
28 Peripheral Nervous System Agents Phase 1, Phase 2
29 Anti-Inflammatory Agents Phase 1, Phase 2
30 Autonomic Agents Phase 1, Phase 2
31 Fat Emulsions, Intravenous Phase 1, Phase 2
32 Soy Bean Nutraceutical Phase 1, Phase 2
33 Olive Nutraceutical Phase 1, Phase 2
34 Omega 3 Fatty Acid Nutraceutical Phase 1, Phase 2
35
Sevoflurane Approved, Vet_approved 28523-86-6 5206
36
Prednisone Approved, Vet_approved 53-03-2 5865
37
Phenobarbital Approved 50-06-6 4763
38 Ether
39 Hematoporphyrins
40 Dermatologic Agents
41 Anesthetics
42 Anesthetics, General
43 Anesthetics, Inhalation
44 Photosensitizing Agents
45 Platelet Aggregation Inhibitors
46 Bile Acids and Salts
47 Central Nervous System Depressants
48 Immunoglobulin G
49 Immunoglobulins
50 Antibodies

Interventional clinical trials:

(show all 46)
id Name Status NCT ID Phase
1 Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice Unknown status NCT00731419 Phase 4
2 Human Kidney Histopathology in Obstructive Jaundice Completed NCT01090193 Phase 4
3 Covered vs. Uncovered SEMS for Occluded Biliary Metal Stents Completed NCT01315522 Phase 4
4 Antibiotics to Decrease Post ERCP Cholangitis Recruiting NCT03087656 Phase 4
5 Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice Unknown status NCT01744938 Phase 3
6 RFA RCT for Pancreatic or Bile Duct Cancer Unknown status NCT02166190 Phase 3
7 Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. Completed NCT00391183 Phase 2, Phase 3
8 Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures Recruiting NCT01721174 Phase 2, Phase 3
9 Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma Recruiting NCT01755013 Phase 2, Phase 3
10 WallFlex Biliary Fully Covered (FC) Benign Stricture Study Active, not recruiting NCT01014390 Phase 3
11 Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction Withdrawn NCT01622803 Phase 3
12 The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice Unknown status NCT01688375 Phase 2
13 Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice Unknown status NCT01275768 Phase 1, Phase 2
14 Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy Unknown status NCT01941342 Phase 2
15 Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors. Completed NCT02166840 Phase 2
16 Radiofrequency Ablation for Biliopancreatic Malignancy Completed NCT02468076 Phase 2
17 Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation. Recruiting NCT02279147 Phase 1, Phase 2
18 EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent Recruiting NCT03002051 Phase 2
19 SMOFlipid to Lessen the Severity of Neonatal Cholestasis Terminated NCT02721277 Phase 1, Phase 2
20 Immune Function in Patients With Obstructive Jaundice Unknown status NCT01367821
21 Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice Unknown status NCT00155194
22 Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage Unknown status NCT01686425
23 Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers Completed NCT01134276
24 Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional Cannulation Completed NCT02477228
25 Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma Completed NCT01506115
26 Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer Completed NCT00409864
27 Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) Completed NCT00196105
28 Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP) Completed NCT01321203
29 Biliary Atresia, Hepatic Buffer Response and Sevoflurane Completed NCT02471209
30 Early Versus Late Cholecystectomy After Clearance of Common Bile Duct Stones Completed NCT02460315
31 Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures Completed NCT01580709
32 Expression of BCRP in Icteric Patients Completed NCT00295360
33 Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids Recruiting NCT02797665
34 Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression Recruiting NCT01191814
35 Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation Recruiting NCT03133026
36 Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression Recruiting NCT01675908
37 Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction Recruiting NCT02937246
38 The Necessity of Bile Cultures in Patients With Acute Cholangitis Recruiting NCT02601417
39 Study of Abdominal Drainage in LCBDE+PC Recruiting NCT03120754
40 A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction Recruiting NCT02659852
41 Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study Recruiting NCT02646514
42 Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders Recruiting NCT01438385
43 Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis Enrolling by invitation NCT02841800
44 A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction Terminated NCT01514058
45 Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP Withdrawn NCT01439685
46 Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent Withdrawn NCT01875549

Search NIH Clinical Center for Obstructive Jaundice

Cochrane evidence based reviews: jaundice, obstructive

Genetic Tests for Obstructive Jaundice

Anatomical Context for Obstructive Jaundice

MalaCards organs/tissues related to Obstructive Jaundice:

39
Liver, Pancreas, Lung, Lymph Node, Brain, Myeloid, B Cells

Publications for Obstructive Jaundice

Articles related to Obstructive Jaundice:

(show top 50) (show all 704)
id Title Authors Year
1
My First Patient: More Than Obstructive Jaundice. ( 28027099 )
2017
2
Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice. ( 27874286 )
2017
3
Obstructive Jaundice Caused by Hepatic Torsion in an Infant with Congenital Diaphragmatic Hernia. ( 28082781 )
2017
4
Spontaneous Intramural Duodenal Hematoma: Pancreatitis, Obstructive Jaundice, and Upper Intestinal Obstruction. ( 27891286 )
2016
5
Obstructive jaundice caused by a pancreaticoduodenal pseudoaneurysm. ( 27324520 )
2016
6
Incidental Diagnosis of MEN1 Syndrome in a Pediatric Patient Presenting With Obstructive Jaundice and Abdominal Pain. ( 27144202 )
2016
7
Temporary placement of a covered duodenal stent can avoid riskier anterograde biliary drainage when ERCP for obstructive jaundice fails due to duodenal invasion. ( 27324333 )
2016
8
Hepatocellular Carcinoma With Budd-Chiari Syndrome and Obstructive Jaundice: A Therapeutic Challenge. ( 27661754 )
2016
9
Aggressive Surgery for Locally Advanced Gallbladder Cancer with Obstructive Jaundice: Result of a Prospective Study. ( 26918527 )
2016
10
Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. ( 27391646 )
2016
11
Immune dysfunction in patients with obstructive jaundice before and after endoscopic retrograde cholangiopancreatography. ( 27252406 )
2016
12
Murine model of long-term obstructive jaundice. ( 27916350 )
2016
13
Obstructive Jaundice from Metastatic Squamous Cell Carcinoma of the Lung. ( 27389381 )
2016
14
Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients. ( 27241392 )
2016
15
Erratum to: Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort study. ( 27651023 )
2016
16
Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. ( 27400651 )
2016
17
Obstructive Jaundice as a Complication of Macrocystic Serous Cystadenoma of the Pancreas. ( 27550882 )
2016
18
Uterine cancer presenting as obstructive jaundice. ( 27462179 )
2016
19
Plasma BNP level combined with surgical Apgar score to predict operative major cardiac adverse events in malignant obstructive jaundice patients. ( 27882019 )
2016
20
Overexcited MaxiK and KATP channels underlie obstructive jaundice-induced vasoconstrictor hyporeactivity of arterial smooth muscle. ( 28000721 )
2016
21
Strongyloides stercoralis Infection Causing Obstructive Jaundice and Refractory Pancreatitis: A Lesson Learned from a Case Study. ( 27477420 )
2016
22
Polycystic liver disease complicated by obstructive jaundice. ( 26718392 )
2016
23
Erratum to: Intermittent Obstructive Jaundice Following Gastric Band Placement. ( 26883930 )
2016
24
Bile acid receptor TGR5 overexpression is associated with decreased intestinal mucosal injury and epithelial cell proliferation in obstructive jaundice. ( 28034761 )
2016
25
Primary Bile Duct Melanoma Causing Obstructive Jaundice. ( 27807580 )
2016
26
Comment re: "Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting". ( 27329667 )
2016
27
Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting. ( 27107633 )
2016
28
An interesting case of obstructive jaundice. ( 27728263 )
2016
29
Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice. ( 27006124 )
2016
30
An Unusual Case of Obstructive Jaundice Owing to an Extrabiliary Mass. ( 27814999 )
2016
31
The role of growth factors on hepatic damage in rats with obstructive jaundice. ( 27540507 )
2016
32
A pilot study of intraluminal brachytherapy using (125)I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. ( 27364870 )
2016
33
Cost Effectiveness of Metal Stents in Relieving Obstructive Jaundice in Patients with Pancreatic Cancer. ( 28025817 )
2016
34
Value and Accuracy of Multidetector Computed Tomography in Obstructive Jaundice. ( 27429673 )
2016
35
Current Status of Percutaneous Transhepatic Biliary Drainage in Palliation of Malignant Obstructive Jaundice: A Review. ( 27803558 )
2016
36
Gastrointestinal bleeding and obstructive jaundice: Think of hepatic artery aneurysm. ( 27358680 )
2016
37
The protective effects of pomegranate on liver and remote organs caused by experimental obstructive jaundice model. ( 26957283 )
2016
38
Value of percutaneous transhepatic cholangiobiopsy for pathologic diagnosis of obstructive jaundice: analysis of 826 cases. ( 26917786 )
2016
39
Ginsenoside Rg1 prevents cerebral and cerebellar injury induced by obstructive jaundice in rats via inducing expression of TIPE-2. ( 26592478 )
2016
40
Bilateral intrahepatic bile duct compression by giant non-parasitic hepatic cyst: A rare cause of obstructive jaundice. ( 27296070 )
2016
41
Combined Stent Insertion and High-intensity Focused Ultrasound Ablation for Patients With Malignant Obstructive Jaundice. ( 27783026 )
2016
42
An uncommon cause of obstructive jaundice: An infrequent neoplastic etiology. ( 27637596 )
2016
43
Hydrogen-rich saline protects against mitochondrial dysfunction and apoptosis in mice with obstructive jaundice. ( 26936224 )
2016
44
Novel approach to recanalizing an occluded cystic duct after cholecystoduodenostomy by lumen-apposing metal mesh stent for malignant obstructive jaundice. ( 26684605 )
2016
45
Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress. ( 26236101 )
2015
46
Unusual cause of obstructive jaundice revealed by endoscopic ultrasound guided fine-needle aspiration of mediastinal lymph node. ( 25789290 )
2015
47
Extra-osseous Ewing's sarcoma presenting as obstructive jaundice. ( 26591961 )
2015
48
Obstructive jaundice secondary to paracoccidioidomycosis. ( 26591954 )
2015
49
Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats. ( 25593463 )
2015
50
CA 19-9 in the presence of obstructive jaundice due to Mirizzi syndrome. ( 25739181 )
2015

Variations for Obstructive Jaundice

Expression for Obstructive Jaundice

Search GEO for disease gene expression data for Obstructive Jaundice.

Pathways for Obstructive Jaundice

GO Terms for Obstructive Jaundice

Cellular components related to Obstructive Jaundice according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.65 ALB CXCL8 EDN1 F2 HGF IL6
2 external side of plasma membrane GO:0009897 9.46 CD79A F2 IL6 TNF
3 extracellular space GO:0005615 9.36 ALB CXCL8 EDN1 F2 GGT1 GPT

Biological processes related to Obstructive Jaundice according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.61 EDN1 IL6 TNF
2 cellular protein metabolic process GO:0044267 9.56 ALB F2 IL6 TTR
3 cellular response to interleukin-1 GO:0071347 9.54 CXCL8 EDN1 IL6
4 positive regulation of chemokine production GO:0032722 9.48 IL6 TNF
5 cellular response to hepatocyte growth factor stimulus GO:0035729 9.46 HGF IL6
6 negative regulation of hormone secretion GO:0046888 9.4 EDN1 IL6
7 positive regulation of smooth muscle cell proliferation GO:0048661 9.33 EDN1 IL6 TNF
8 negative regulation of lipid storage GO:0010888 9.32 IL6 TNF
9 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 8.96 IL6 TNF
10 positive regulation of nitric oxide biosynthetic process GO:0045429 8.8 EDN1 IL6 TNF

Molecular functions related to Obstructive Jaundice according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.92 CXCL8 EDN1 IL6 TNF

Sources for Obstructive Jaundice

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....